The store will not work correctly when cookies are disabled.
4-butyryl-3-mesityl-1-oxaspiro[4.4]non-3-en-2-one
ID: ALA2287733
PubChem CID: 76309247
Max Phase: Preclinical
Molecular Formula: C21H26O3
Molecular Weight: 326.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCC(=O)C1=C(c2c(C)cc(C)cc2C)C(=O)OC12CCCC2
Standard InChI: InChI=1S/C21H26O3/c1-5-8-16(22)19-18(17-14(3)11-13(2)12-15(17)4)20(23)24-21(19)9-6-7-10-21/h11-12H,5-10H2,1-4H3
Standard InChI Key: KSISTUKDXPQPRZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
11.2534 -16.4913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0071 -16.1745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9388 -15.3598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1428 -15.1730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7193 -15.8723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3368 -16.6698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3357 -17.4894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0437 -17.8983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7534 -17.4889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7505 -16.6662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0419 -16.2610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0395 -15.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6276 -17.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4617 -17.8964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4569 -16.2549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2275 -16.5225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2502 -15.2004 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4689 -15.4397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8154 -14.9489 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4647 -17.3046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2479 -18.0896 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2818 -17.2943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6992 -17.9968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5164 -17.9866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
11 12 1 0
7 13 1 0
9 14 1 0
10 15 1 0
15 16 2 0
16 5 1 0
5 17 1 0
17 18 1 0
18 15 1 0
18 19 2 0
16 20 1 0
20 21 2 0
20 22 1 0
22 23 1 0
23 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 326.44 | Molecular Weight (Monoisotopic): 326.1882 | AlogP: 4.60 | #Rotatable Bonds: 4 |
Polar Surface Area: 43.37 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.93 | CX LogD: 5.93 |
Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.76 | Np Likeness Score: 0.27 |
References
1. Zhao JH, Wang ZC, Ji MH, Cheng JL, Zhu GN, Yu CM.. (2012) Synthesis and bioactivity evaluation of novel spiromesifen derivatives., 68 (1): [PMID:21997953] [10.1002/ps.2248] |